Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nutrition Disorders × Tamoxifen × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 228 Carcinoma, Intraductal, Noninfiltrating 19 Breast Carcinoma In Situ 15 Neoplasm Metastasis 13 Neoplasms 11 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Prostatic Neoplasms 3 Obesity 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Breast Cancer Female 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Recurrence 2 Multiple Endocrine Neoplasia Type 1 2 Hot Flashes 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Astrocytoma 2 Vitamin D Deficiency 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

exemestane 1 Tamoxifen 1 Sulfasalazine 1 Saline Solution 1 Preoperative Exercise 1 Oxycodone 1 Olanzapine 1 Octreotide 1 Nutrition Therapy 1 Megestrol Acetate 1 Anastrozole 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389424 2020-05-15

NUTRIBREAST

Instituto Jalisciense de Cancerologia

Breast Neoplasms, Nutrition Disorders, Obesity, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡